What is LOPJLB’s current signal on ELAB?

LOPJLB’s latest quantitative signal on PMGC Holdings Inc. (ELAB) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ELAB in?

PMGC Holdings Inc. (ELAB) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does PMGC Holdings Inc. (ELAB) do?

PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operatio…

PMGC Holdings Inc. (ELAB)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.97+0.34%Close

SELLCRISIS · day 12

Company news

globenewswire.com · 7d ago

PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update

globenewswire.com · 14d ago

PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy

globenewswire.com · 16d ago

NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs

globenewswire.com · 27d ago

PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings

globenewswire.com · 44d ago

NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications

globenewswire.com · 50d ago

PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio

globenewswire.com · 51d ago

PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss

globenewswire.com · 55d ago

NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight

globenewswire.com · 57d ago

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

globenewswire.com · 62d ago

PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially

globenewswire.com · 78d ago

PMGC Holdings Confirms Compliance with Nasdaq's New $5 Million Market Value of Listed Securities Requirement

globenewswire.com · 79d ago

PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.

globenewswire.com · 79d ago

PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.

globenewswire.com · 80d ago

NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License

Market news & ticker search · RSS for ELAB

FAQ

What is LOPJLB’s current signal on ELAB?: LOPJLB’s latest quantitative signal on PMGC Holdings Inc. (ELAB) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is ELAB in?: PMGC Holdings Inc. (ELAB) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does PMGC Holdings Inc. (ELAB) do?: PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operatio…

PMGC Holdings Inc. (ELAB)

Key stats

Prediction markets

Company news

FAQ